DNA topoisomerase II rescue by catalytic inhibitors
- 1 October 1997
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (7) , 755-759
- https://doi.org/10.1016/s0006-2952(97)00116-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycleBiochemical Pharmacology, 1996
- DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanismCell, 1994
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)Biochemical Pharmacology, 1993
- Different modes of anthracycline interaction with topoisomerase II: Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistanceBiochemical Pharmacology, 1993
- Mode of action of topoisomerase II-targeting agents at a specific DNA sequence: Uncoupling the DNA binding, cleavage and religation eventsJournal of Molecular Biology, 1992
- Management of small-cell cancer of the lungThe Lancet, 1992
- DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cellsBiochemistry, 1989
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavageBiochemical Pharmacology, 1985